Scientists have developed a new tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation, therapies that are widely used for the treatment of cancer. The research study, published in the October issue of Cancer Cell, provides evidence that a genetically engineered mouse model faithfully recapitulates treatment-associated cancers that occur in humans and may be useful for investigating the mechanisms involved in the development of therapy-induced cancers and for testing preventive strategies.
Secondary malignant neoplasms (SMNs) are new cancers that patients develop as a result of having received chemotherapy or radiation to treat a different type of cancer that may have occurred years earlier. To make matters worse, many of these secondary cancers are notoriously resistant to treatment. The occurrence of SMNs is a serious concern for doctors and patients, as the use of intensive radiation and chemotherapy has been more successful in curing primary cancers and has dramatically increased survival rates in children and adults. Unfortunately, as a result of treatment success, the incidence of SMNs has also risen. "The lack of relevant animal models of SMNs has impeded efforts to understand how mutagenic cancer therapeutics induce tumors in vivo, and to test preventive strategies," explains study author Dr. Kevin Shannon, a pediatric oncologist at the University of California, San Francisco.
Dr. Shannon and colleagues used a strain of mice developed in the laboratory of Dr. Tyler Jacks that carry a mutation in a tumor suppressor gene called Nf1. They selected this strain based on clinical data suggesting that humans who inherit this mutation are predisposed to SMNs. Nf1 mutant mice that were exposed to radiation, or radiation combined with chemotherapy, developed secondary cancers that are common in humans including leukemia, sarcoma, and breast cancers. "These animals develop a similar spectrum of malignancies as human patients who are treated with radiation and alkylating agents, and provide a tractable system for performing mechanistic studies, for comparing the mutagenic potential of different regimens, and for testing preventive strategies," offers Dr. Shannon. The study authors also suggest that this mouse model may be useful for testing novel therapeutic strategies for tumors that are resistant to conventional cancer therapies.
Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena
Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University
A study carried out by an international team of researchers and published in the journal Physical Review X shows that ion-trap technologies available today are suitable for building large-scale quantum computers. The scientists introduce trapped-ion quantum error correction protocols that detect and correct processing errors.
In order to reach their full potential, today’s quantum computer prototypes have to meet specific criteria: First, they have to be made bigger, which means...
Since 2016, German and Spanish researchers, among them scientists from the University of Göttingen, have been hunting for exoplanets with the “Carmenes”...
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
18.12.2017 | Life Sciences
18.12.2017 | Materials Sciences
18.12.2017 | Life Sciences